Watch NBC6 free wherever you are Trish Webster started taking Ozempicthe trade name of an injectable medication called semaglutide developed to treat type 2 diabetesafter struggling to lose weight through traditional means, her husband Roy Webster told "60 Minutes Australia." The 56-year-old, who did not have diabetes, saw a TV ad for Ozempic and obtained a prescription from her doctor in 2022 after learning that significant weight loss was one of the drug's side effects
The patient wants to switch to Zepbound because "it's stronger." The argument against: the patient is responding well to current therapy
In parallel, the reduction in glycemic burden induced by GLP-1 activity creates a metabolic milieu that may restore GIPR sensitivity and functionality
Liu, T., Zhang, L., Joo, D
Some patients receive a bag of fluids before the infusion, while others get them after, or even both before and after the procedure